E.U. Closes In On Pediatric Drug Patent Extensions

Law360, New York (June 1, 2006, 12:00 AM EDT) -- In the European Union, a bid to extend patent protection on some drugs in return for pediatric research has once again been approved by the European Parliament, after objections from the generic drug industry were overwhelmed by support for the proposal.

The proposal would grant pharmaceutical companies an additional six months of patent protection if new drugs are tested specifically on children before they are cleared for pediatric use.

Having passed muster in the Brussels-based parliament, the proposal must now be rubber-stamped by the European Council,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.